Sun, E., & Karaoz, E. (2020). Can Wharton jelly derived or adipose tissue derived mesenchymal stem cell can be a treatment option for duchenne muscular dystrophy? Answers as transcriptomic aspect. Am J Stem Cells.
Chicago Style aipamenaSun, Eda, and Erdal Karaoz. "Can Wharton Jelly Derived or Adipose Tissue Derived Mesenchymal Stem Cell Can Be a Treatment Option for Duchenne Muscular Dystrophy? Answers As Transcriptomic Aspect." Am J Stem Cells 2020.
MLA aipamenaSun, Eda, and Erdal Karaoz. "Can Wharton Jelly Derived or Adipose Tissue Derived Mesenchymal Stem Cell Can Be a Treatment Option for Duchenne Muscular Dystrophy? Answers As Transcriptomic Aspect." Am J Stem Cells 2020.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.